Case number PHHY2015FR112584, is an initial spontaneous report from a health care professional received on 15
Sep 2015. This report refers to a 71-year-old female patient. Medical history included venous thrombosis and 
pulmonary embolism. Concurrent conditions included b-cell lymphoma. No concomitant medication was reported. 
The patient intravenously received Doxorubicina Ebewe, Endoxan (cyclophosphamide) 750mg/m2, Vincristine 
Hospira 2mg/m2, Methylprednisolone Mylan 60mg, Uromitexan at an unknown dose on 08 Oct 2011, orally 
Cortancyl (prednisone) 60mg on 09 Oct 2011 and intravenously Mabthera (rituximab) 350mg/m2 for the treatment 
of b-cell lymphoma. On an unknown date in Aug 2012 the patient developed progressive multifocal 
leukoencephalopathy. The following significant lab tests were recorded: lumbar puncture on an unknown date was 
abnormal (positive JC virus). The patient died due to unknown reason on (b) (6)  It was unknown if an 
autopsy was performed. Action taken with the suspect drug was not applicable. The outcome of the event was fatal.
Seriousness assessment of events was considered medically significant (Fatal) based on information available in 
the source document. The causality of the event was not reported.